Apollo Health Ventures is a transatlantic early-stage Venture Capital firm actively co-founding and investing in transformative healthcare companies. Their primary focus is on companies targeting age-related diseases and aging itself. They believe that biotechnology is the solution for a healthier lifespan and reduced healthcare spending. They aim to impact human health within the next 10 years by enabling transformative healthcare companies in their scientific breakthroughs. The firm leverages a Venture Lab to identify company-building opportunities and maintains close ties with leading research institutions and researchers in the aging sector.
Preferred startup development maturity for initial funding deployment.
Age-related diseases, aging, biotechnology, therapeutics, health tech, oncology, inflammatory diseases, fibrotic diseases, neurodegenerative diseases
Core thematic spaces, technologies, and target market segments of interest.
Standard financial allocation per investment round.
Direct Verification Contact Email Pattern
Thesis Dossier Analysis Scorecard
Our agent analyzer scanned portfolio holdings and verified absolute match parameters...